Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 12, 2016 - Issue 1
391
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study

, PhD, , MSN, RN, , MD, , MD & , MD, MPH

References

  • Bahorik, A. L., Newhill, C. E., & Eack, S. M. (2014). Neurocognitive functioning of individuals with schizophrenia using and not using drugs. Schizophrenia Bulletin, 40(4), 856–867. doi:10.1093/schbul/sbt099
  • Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., … Tarrier, N. (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: Randomised controlled trial. BMJ, 341, c6325. doi:10.1136/bmj.c6325
  • Bates, M. E., Buckman, J. F., & Nguyen, T. T. (2013). A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychology Review, 23(1), 27–47. doi:10.1007/s11065-013-9228-3
  • Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63(4), 426–432. doi:10.1001/archpsyc.63.4.426
  • Ben-Yishay, Y., Piasetsky, E. B., & Rattok, J. (1985). A systematic method for ameliorating disorders in basic attention. In M. J. Meir, A. L. Benton, & L. Diller (Eds.), Neuropsychological rehabilitation (pp. 165–181). New York, NY: Guilford Press.
  • Bracy, O. L. (1994). PSSCogRehab [computer software]. Indianapolis, IN: Psychological Software Services Inc.
  • Braw, Y., Bloch, Y., Mendelovich, S., Ratzoni, G., Gal, G., Harari, H., … Levkovitz, Y. (2008). Cognition in young schizophrenia outpatients: Comparison of first-episode with multiepisode patients. Schizophrenia Bulletin, 34(3), 544–554. doi:10.1093/schbul/sbm115
  • Breslow, N. E., & Clayton, D. G. (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association, 88(421), 9–25. doi:10.1111/j.1467-9469.2008.00621.x
  • Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977). Maximum likelihood from incomplete data using the EM algorithm. Journal of the Royal Statistical Society. Series B (Methodological), 39(1), 1–38. doi:10.1016/j.fss.2011.05.022
  • Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., … Kreyenbuhl, J. (2009). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 48–70. doi:10.3410/f.13847960.15286060
  • Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123–138. doi:10.1016/j.jsat.2007.01.011
  • Drake, R. E., Osher, F. C., & Wallach, M. A. (1989). Alcohol use and abuse in schizophrenia: A prospective community study. Journal of Nervous and Mental Disease, 177(7), 408–414. doi:10.1097/00005053-198907000-00004
  • Dutra, L., Stathopoulou, G., Basden, S., Leyro, T., Powers, M., & Otto, M. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165(2), 179–187. doi:10.1176/appi.ajp.2007.06111851
  • Eack, S. M. (2012). Cognitive remediation: A new generation of psychosocial interventions for people with schizophrenia. Social Work, 57(3), 235–246. doi:10.1093/sw/sws008
  • Eack, S. M., Hogarty, S. S., Greenwald, D. P., Litschge, M. Y., McKnight, S. A. F., Bangalore, S. S., … Cornelius, J. R. (2015). Cognitive enhancement therapy in substance misusing schizophrenia: Results of an 18-month feasibility trial. Schizophrenia Research, 161(2–3), 478–483. doi:10.1016/j.schres.2014.11.017
  • First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B. W. (2002). Structured Clinical Interview For DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute.
  • Green, A. I., Drake, R. E., Brunette, M. F., & Noordsy, D. L. (2007). Schizophrenia and co-occurring substance use disorder. American Journal of Psychiatry, 164(3), 402–408. doi:10.1093/schbul/sbl020
  • Green, M. F., Bearden, C. E., Cannon, T. D., Fiske, A. P., Hellemann, G. S., Horan, W. P., … Nuechterlein, K. H. (2012). Social cognition in schizophrenia, Part 1: Performance across phase of illness. Schizophrenia Bulletin, 38(4), 854–864. doi:10.3410/f.9900956.10612054
  • Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., … Keefe, R. S. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry, 56(5), 301–307. doi:10.1016/j.biopsych.2004.06.023
  • Heinrichs, R. W., & Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12(3), 426–445. doi:10.1037/0894-4105.12.3.426
  • Hjorthøj, C. R., Fohlmann, A., Larsen, A. M., Arendt, M., & Nordentoft, M. (2012). Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction, 107(6), 1123–1131. doi:10.1111/j.1360-0443.2011.03757.x
  • Hjorthøj, C. R., Hjorthøj, A. R., & Nordentoft, M. (2012). Validity of timeline follow-back for self-reported use of cannabis and other illicit substances—systematic review and meta-analysis. Addictive behaviors, 37(3), 225–233. doi:10.1016/j.addbeh.2011.11.025
  • Hogarty, G. E. (2002). Personal therapy for schizophrenia and related disorders: A guide to individualized treatment. New York, NY: Guilford.
  • Hogarty, G. E., Flesher, S., Ulrich, R., Carter, M., Greenwald, D., Pogue-Geile, M., … Zoretich, R. (2004). Cognitive enhancement therapy for schizophrenia. Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry, 61(9), 866–876. doi:10.1001/archpsyc.61.9.866
  • Hogarty, G. E., & Greenwald, D. P. (2006). Cognitive enhancement therapy: The training manual. Pittsburgh, PA; CET Training, LLC. Retrieved from www.cognitiveenhancementtherapy.com.
  • Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., … Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, Part 2: Co-norming and standardization. American Journal of Psychiatry, 165(2), 214–220. doi:10.1176/appi.ajp.2007.07010043
  • Mayer, J. D., Salovey, P., Caruso, D. R., & Sitarenios, G. (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion, 3(1), 97–105. doi:10.1037/1528-3542.3.1.97
  • McGurk, S. R., Mueser, K. T., Feldman, K., Wolfe, R., & Pascaris, A. (2007). Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. American Journal of Psychiatry, 164(3), 437–441. doi:10.1176/appi.ajp.164.3.437
  • McGurk, S. R., Twamley, E. W., Sitzer, D. I., McHugo, G. J., & Mueser, K. T. (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry, 164(12), 1791–1802. doi:10.3410/f.9528958.12046055
  • McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease, 168(1), 26–33. doi:10.1097/00005053-198001000-00006
  • Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., … Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, Part 1: Test selection, reliability, and validity. American Journal of Psychiatry, 165(2), 203–213. doi:10.1176/appi.ajp.2007.07010042
  • Perlstein, W. M., Carter, C. S., Noll, D. C., & Cohen, J. D. (2001). Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. American Journal of Psychiatry, 158(7), 1105–1113. doi:10.1176/appi.ajp.158.7.1105
  • Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390–395. doi:10.1037/0022-006x.51.3.390
  • Raudenbush, S. W., & Xiao-Feng, L. (2001). Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychological Methods, 6(4), 387–401. doi:10.1037/1082-989x.6.4.387
  • Savla, G. N., Vella, L., Armstrong, C. C., Penn, D. L., & Twamley, E. W. (2013). Deficits in domains of social cognition in schizophrenia: A meta-analysis of the empirical evidence. Schizophrenia Bulletin, 39(5), 979–992. doi:10.1093/schbul/sbs080
  • Schweinsburg, A. D., Nagel, B. J., Schweinsburg, B. C., Park, A., Theilmann, R. J., & Tapert, S. F. (2008). Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Research: Neuroimaging, 163(1), 40–51. doi:10.1016/j.pscychresns.2007.04.018
  • Singer, J. D., & Willet, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford University Press.
  • Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back. In R. Z. Litten, & J. Allen (Eds.), Measuring alcohol consumption: Psychosocial and biological methods (pp. 41–72). Totowa, NJ: Humana Press.
  • Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013). Cognitive enhancement as a treatment for drug addictions. Neuropharmacology, 64, 452–463. doi:10.1016/j.neuropharm.2012.06.021
  • Thoma, P., & Daum, I. (2013). Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings. Psychiatry and Clinical Neurosciences, 67(6), 367–383. doi:10.1111/pcn.12072
  • Volkow, N. D. (2009). Substance use disorders in schizophrenia—Clinical implications of comorbidity. Schizophrenia Bulletin, 35(3), 469–472. doi:10.1093/schbul/sbp016
  • Wobrock, T., Falkai, P., Schneider-Axmann, T., Hasan, A., Galderisi, S., Davidson, M., … EUFEST study group. (2013). Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research, 147(1), 132–139. doi:10.1016/j.schres.2013.03.001
  • Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. American Journal of Psychiatry, 168(5), 472–485. doi:10.3410/f.9528958.12046055
  • Yücel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., … Pantelis, C. (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin, 38(2), 316–330. doi:10.1093/schbul/sbq079

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.